ABSTRACT
Esophageal melanomas correspond to 0.1 to 0.2 percent of esophageal tumors. We report two patients with the disease. The first patient is a 51 year-old woman pre-sentingwith dysphagia and weight loss. An upper gastrointestinal endoscopy showed a polypoid ulcerated lesion in the middle third of the esophagus. The pathological study ofthe biopsy disclosed a malignant melanoma. The patient was subjected to an esophagectomy with a satisfactory postoperative evolution. Four months later, liver metastases were detected and the patient died eleven months after the operation. The second patient is a 59 year-old mole that consulted by dysphagia. An endoscopy showed a pigmented esophageal lesion whose pathological diagnosis was a malignant melanoma. The patient was subjected to an esophagectomy and sixteen months after surgery there was no evidence of relapse.
Subject(s)
Female , Humans , Male , Middle Aged , Esophageal Neoplasms/pathology , Melanoma/pathology , Esophageal Neoplasms/surgery , Esophagectomy/methods , Fatal Outcome , Liver Neoplasms/secondary , Melanoma/surgeryABSTRACT
Propósito. Los TNE avanzados tienen escasa respuesta a radioterapia o quimioterapia, el tratamiento sistémico con análogos de la SST radiactivos es una herramienta promisoria en su tratamiento. Presentamos nuestra experiencia, pionera en Latinoamérica, utilizando análogos de SST marcados con 90Y ó 177Lu. Material. Evaluamos 40 pacientes (50.3 años, rango 12-74) con TNE confirmados histológicamente y sobre-expresión de receptores de SST demostrada mediante imágenes. SPECT (111In-DOTATOC) ó PET/CT (68Ga-DOTATATE). Se evaluó respuesta clínica, laboratorio, imágenes con 111In-DOTATATE, post-terapia con 90Y ó 177Lu, 68Ga-DOTATATE PET/CT o TAC. Resultados. Observamos progresión de enfermedad en 10 (25.0 por ciento), remisión parcial en 25 (62.5 por ciento), enfermedad estable en 3 (7.5 por ciento) y remisión completa en 2 (5.0 por ciento). Hubo escasa toxicidad sin deterioro renal significativo. Observamos reducción tumoral y mejoría de calidad de vida en la mayoría de los pacientes. Conclusión. La terapia con radiopéptidos es un procedimento seguro y efectivo en el tratamiento de TNE avanzados.
Purpose. Advanced NETs have little response to radiotherapy or chemotherapy, systemic treatment with radioactive SST analogous is a promissory tool in its treatment. We present our pioneering experience in Latin America using analogous of SST labeled either with 90Y or 177Lu. Materials. We evaluated 40 patients (50.3 years, range 12-74) with histological proved NET and SST receptors over-expression demonstrated by SPECT or PET/CT images with 111In-DOTATOC or 68Ga-DOTATATE. We evaluated clinical response, laboratory test, images with 111In-DOTATATE, 90Y, 177Lu, and 68Ga-DOTATATE PET/CT or CT. Results. We observed progression of disease in 10 (7,5 percent), partial remission in 25 (62,5 percent), stable disease in 3 (7,5 percent) and complete remission in 2 (5,0 percent). There was little toxicity without significant renal deterioration. We observed tumor mass reduction and improvement of quality of life in most of the patients. Conclusion. The therapy with radiopeptides is a safe and effective procedure in the treatment of advanced NET.
Subject(s)
Humans , Male , Adolescent , Adult , Female , Middle Aged , Organometallic Compounds/therapeutic use , Radiopharmaceuticals/therapeutic use , Somatostatin/analogs & derivatives , Neuroendocrine Tumors/radiotherapy , Remission Induction , Lutetium/therapeutic use , Octreotide/analogs & derivatives , Octreotide/therapeutic use , Yttrium Radioisotopes/therapeutic use , Treatment OutcomeABSTRACT
We report a 74-year-old maie with liver metastases from a neuroendocrine tumor (NET) of unknown origin. Conventionai imaging studies with ultrasound, computed tomography coionoscopy and Positron emission tomography-computed tomography (PET/CT) with 18Flúor odeoxyglucose did not identify the site of orígin of the primary tumor. The patient was submitted for a PET/CT sean with a new radiopharmaceuticai, the somatostatin anaiogue 68Ga-DOTATATE. This new technique demostrated increased focal uptake at the ileocecal valve. This lesión and other two liver metastases were surgically removed. The histopathology and immunohistochemistry analysis confirmed the diagnosis of NET (carcinoid). This case illustrates the advantages of the PET/CT sean with 68Ga-DOTATATE.
Subject(s)
Aged , Humans , Male , Ileal Neoplasms , Ileocecal Valve , Neuroendocrine Tumors , Organometallic Compounds , Ileal Neoplasms , Ileal Neoplasms , Ileocecal Valve , Ileocecal Valve , Liver Neoplasms , Liver Neoplasms , Liver Neoplasms/secondary , Neuroendocrine Tumors , Neuroendocrine Tumors , Positron-Emission Tomography/methods , Tomography, X-Ray Computed/methodsABSTRACT
Fibrolamellar hepatocellular carcinoma (FLC) is a rare histologic variant of hepatocellular carcinoma that appears most commonly in teenagers and young adults. The diagnosis is often made incidentally and surgical resection is the only curative treatment. Here we report two cases of incidental FLC involving a 19 year-old male, initially diagnosed with screening abdominal ultrasound, and a 14 year-old female that presented with abdominal pain. Diagnostic workup consisted of abdominal PET/CT and MRI Imaging studies and tissue diagnosis was confirmed with percutaneous liver biopsy. Both patients were treated with radical liver resection/tumor excision. However, tumor recurrence was observed in both during short-term follow-up. The male patient was treated successfully with surgical treatment however the female patient succumbed top regression of disease.
Subject(s)
Adolescent , Female , Humans , Male , Young Adult , Carcinoma, Hepatocellular/surgery , Liver Neoplasms/surgery , Biopsy , Carcinoma, Hepatocellular/pathology , Fatal Outcome , Focal Nodular Hyperplasia/pathology , Focal Nodular Hyperplasia/surgery , Liver Neoplasms/pathology , Lymph Nodes/pathology , Neoplasm Recurrence, Local , Tomography, X-Ray Computed , Young AdultSubject(s)
Humans , Male , Adult , Abdominal Wall , Thoracic Wall , Tomography, X-Ray Computed , Positron-Emission Tomography , Tuberculosis/diagnosis , RadiopharmaceuticalsABSTRACT
In January 2008, we set up a 68Ge/ 68Ga generator able to produce enough quantities of 68Ga to label the same polypeptides, somatostatin analogos, used to treat patients suffering from neuroendocrine tumors. As far as we know, this is the first time that such a device is installed in Latin-America for specific PET/CT imaging different from 18F. During the last three months we have studied 30 patients for staging, re-staging and treatment control of neuroendocrine tumors using PET/CT images with 68Ga-DOTATATE. In all cases the image quality was excellent, providing clinically useful information in most of them. 68Ga is a very promising positron emitter radionuclide, cyclotron-independent, to label peptides and other molecules that open a wide window for Molecular Imaging.
En Enero de 2008 instalamos un generador de 68Ge/ 68Ga capaz de producir cantidades suficientes de 68Ga para marcar los mismos péptidos, análogos de la somatostatina, utilizados para el tratamiento de pacientes con tumores neuroendocrinos. De acuerdo con nuestro conocimiento, esta es la primera vez que se utilizada este aparato en Latinoamérica para obtener imágenes PET/CT específicas con un agente diferente al 18F. Durante los últimos tres meses hemos estudiado 30 pacientes con tumores neuroendocrinos con 68Ga-DOTATATE para etapificación, re-etapificación y control de tratamiento mediante imágenes PET/CT. En todos los casos la calidad de la imagen fue excelente proporcionando información clínicamente útil en la mayoría de ellos. 68Ga es un promisorio radionucleido emisor de positrones, independiente de un ciclotrón, para marcar péptidos y otras moléculas abriendo una amplia ventana para las Imágenes Moleculares.
Subject(s)
Humans , Radionuclide Generators , Gallium Radioisotopes , Tomography, X-Ray Computed/methods , Positron-Emission Tomography/methods , Neuroendocrine Tumors , Chile , Organometallic Compounds , Isotope Labeling/methods , RadiopharmaceuticalsSubject(s)
Humans , Female , Sentinel Lymph Node Biopsy/standards , Radionuclide Imaging/standards , Lymphatic Metastasis , Lymphatic Metastasis/pathology , Breast Neoplasms/complications , Lymph Nodes , Lymph Nodes/pathology , Axilla , Carcinoma, Ductal, Breast/complications , Neoplasm Staging/methods , Neoplasm Invasiveness , Neoplasm Invasiveness/pathology , Radiopharmaceuticals , False Negative ReactionsSubject(s)
Humans , Female , Middle Aged , Meningioma/diagnosis , Skull Neoplasms/diagnosis , Meningeal Neoplasms/diagnosis , Skull , Skull , Tomography, X-Ray ComputedABSTRACT
Se presenta un caso de quilotórax de aparición espontánea en una niña de 13 años, sus manifestaciones clínicas, exámenes de laboratorio e imágenes que contribuyeron al diagnóstico, con énfasis en el uso de la linfocintigrafía que permitió detectar el sitio de la filtración de quilo hacia la cavidad pleural y que fue posteriormente confirmado y exitosamente reparado quirúrgicamente
Subject(s)
Humans , Adolescent , Female , Technetium Tc 99m Sulfur Colloid , Lymph Nodes , ChylothoraxABSTRACT
Se presentan 3 casos clínicos de jaqueca acompañada, en quienes se pudo demostrar una reducción transitoria del flujo sanguíneo cerebral regional mediante un SPECT con 99mTc-HMPAO cerebral inyectado durante la fase aguda. En dos de ellos el SPECT de control de 24 horas demostró regresión de las alteraciones de perfusión
Subject(s)
Humans , Male , Adolescent , Female , Adult , Migraine Disorders/diagnosis , Tomography, Emission-Computed, Single-Photon , Cerebrovascular Circulation , Migraine Disorders/physiopathology , Neurologic ManifestationsABSTRACT
Os autores relatam um caso de osteoporose regional transitória idiopática do joelho esquerdo. Salientam o importante papel que tem a imagem no diagnóstico. Um homem de 44 anos apresenta acentuada dor e aumento de volume do joelho esquerdo; radiografia, TC, cintilografia e densitometria dessa articulaçao permitiram formular o diagnóstico. O tratamento com antiinflamatório nao esteróide (AINE) foi incapaz de controlar a dor, que desapareceu, entretanto, rapidamente, quando foi usada calcitonina. Dá-se importância em ter sempre presente esse diagnóstico para evitar procedimentos diagnósticos e/ou terapêuticos mais agressivos